Similar articles for PMID: 16788565

Year	Number of Results
1988	1
1989	1
1990	1
1995	1
1996	1
1999	1
2001	1
2002	7
2003	5
2004	9
2005	8
2006	19
2007	14
2008	15
2009	12
2010	8
2011	9
2012	15
2013	9
2014	13
2015	9
2016	11
2017	8
2018	6
2019	1
2020	5
2021	6
2022	2
2023	1
2024	0

1

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.

Haenisch S, Zimmermann U, Dazert E, Wruck CJ, Dazert P, Siegmund W, Kroemer HK, Warzok RW, Cascorbi I. Haenisch S, et al. Pharmacogenomics J. 2007 Feb;7(1):56-65. doi: 10.1038/sj.tpj.6500403. Epub 2006 Jun 20. Pharmacogenomics J. 2007. PMID: 16788565

2

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.

Han JY, Lim HS, Yoo YK, Shin ES, Park YH, Lee SY, Lee JE, Lee DH, Kim HT, Lee JS. Han JY, et al. Cancer. 2007 Jul 1;110(1):138-47. doi: 10.1002/cncr.22760. Cancer. 2007. PMID: 17534875 Free article. Clinical Trial.

3

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.

Haenisch S, May K, Wegner D, Caliebe A, Cascorbi I, Siegmund W. Haenisch S, et al. Pharmacogenet Genomics. 2008 Apr;18(4):357-65. doi: 10.1097/FPC.0b013e3282f974b7. Pharmacogenet Genomics. 2008. PMID: 18334920

4

Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.

Bernsdorf A, Giessmann T, Modess C, Wegner D, Igelbrink S, Hecker U, Haenisch S, Cascorbi I, Terhaag B, Siegmund W. Bernsdorf A, et al. Br J Clin Pharmacol. 2006 Apr;61(4):440-50. doi: 10.1111/j.1365-2125.2006.02599.x. Br J Clin Pharmacol. 2006. PMID: 16542205 Free PMC article.

5

ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.

Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH, Tang Q, Zhou HH, Liu ZQ. Qu J, et al. CNS Neurosci Ther. 2012 Aug;18(8):647-51. doi: 10.1111/j.1755-5949.2012.00336.x. Epub 2012 May 28. CNS Neurosci Ther. 2012. PMID: 22630058 Free PMC article.

6

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.

Oswald S, Haenisch S, Fricke C, Sudhop T, Remmler C, Giessmann T, Jedlitschky G, Adam U, Dazert E, Warzok R, Wacke W, Cascorbi I, Kroemer HK, Weitschies W, von Bergmann K, Siegmund W. Oswald S, et al. Clin Pharmacol Ther. 2006 Mar;79(3):206-17. doi: 10.1016/j.clpt.2005.11.004. Epub 2006 Feb 7. Clin Pharmacol Ther. 2006. PMID: 16513445

7

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.

Laechelt S, Turrini E, Ruehmkorf A, Siegmund W, Cascorbi I, Haenisch S. Laechelt S, et al. Pharmacogenomics J. 2011 Feb;11(1):25-34. doi: 10.1038/tpj.2010.20. Epub 2010 Mar 30. Pharmacogenomics J. 2011. PMID: 20351751

8

RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.

Materna V, Pleger J, Hoffmann U, Lage H. Materna V, et al. Gynecol Oncol. 2004 Jul;94(1):152-60. doi: 10.1016/j.ygyno.2004.03.035. Gynecol Oncol. 2004. PMID: 15262134

9

Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.

Mosyagin I, Runge U, Schroeder HW, Dazert E, Vogelgesang S, Siegmund W, Warzok RW, Cascorbi I. Mosyagin I, et al. Epilepsia. 2008 Sep;49(9):1555-61. doi: 10.1111/j.1528-1167.2008.01661.x. Epub 2008 May 20. Epilepsia. 2008. PMID: 18494787 Free article.

10

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.

Niemi M, Arnold KA, Backman JT, Pasanen MK, Gödtel-Armbrust U, Wojnowski L, Zanger UM, Neuvonen PJ, Eichelbaum M, Kivistö KT, Lang T. Niemi M, et al. Pharmacogenet Genomics. 2006 Nov;16(11):801-8. doi: 10.1097/01.fpc.0000230422.50962.91. Pharmacogenet Genomics. 2006. PMID: 17047488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

174 results

Results by year